LA Private

April 24, 2024

Stocks of the Hour: Immutep, Western Mines Group, Industrial Minerals

Immutep (ASX:IMM; NASDAQ:IMMP) has announced preliminary topline results from Cohort B of the TACTI-003 Phase IIb trial. The trial evaluates efti in combination with MSD’s anti-PD-1 therapy KEYTRUDA® as first-line treatment for recurrent/metastatic head and neck squamous cell carcinoma patients with negative PD-L1 expression. Shares are trading 10.39 per cent higher at 42.5 cents. Western

Stocks of the Hour: Immutep, Western Mines Group, Industrial Minerals Read More »